Theranostics for Cancer
Theranostics: A Powerful Diagnostic Tool and Cancer Treatment in One
Radiation therapy has been used to fight cancer for more than a century. But when cancer has spread to multiple areas of the body, traditional radiation can be limited—because it’s usually aimed at one location at a time and can affect healthy tissue nearby. Memorial Sloan Kettering (MSK) highlights a newer approach that is changing what’s possible for advanced and metastatic cancers: theranostics.
What Is Theranostics?
Theranostics combines the words therapy and diagnostics. It’s a treatment strategy that uses radioactive medicines to first find cancer cells and then treat them—using the same target. MSK’s theranostics motto captures the concept simply: “We see what we treat, and we treat what we see.”
How Theranostics Works
Theranostics typically happens in two steps:
- Find the cancer (“see it”)
Doctors infuse a patient with a radioactive drug containing a diagnostic isotope that binds to a specific target on cancer cells. Then a PET scan “lights up” where the drug has attached, revealing cancer sites that may be hard to see on standard imaging. - Treat the cancer (“treat it”)
If the target is confirmed, doctors give a treatment version of the same approach—this time loaded with a therapeutic isotope. The radiation works like a highly precise “smart bomb,” damaging cancer cell DNA while helping protect surrounding healthy tissue.
Why Theranostics Is Such a Big Deal
MSK notes several practical advantages of theranostics, especially for cancers that have spread:
- It can reveal the exact location of cancer cells that might be missed on conventional scans.
- It can help doctors evaluate whether treatment is working sooner.
- It can help clinical trials move more efficiently from imaging to treatment phases.
- It can treat multiple sites of disease throughout the body, not just one spot at a time.
- Even when it isn’t a cure, theranostics can be meaningful because it may offer effective control with good tolerability—supporting quality of life and daily living for many patients.
A Real Example: Theranostics for Metastatic Prostate Cancer (Pluvicto)
MSK shares the story of a patient with metastatic (stage 4) prostate cancer who joined a clinical trial using lutetium-177 PSMA-targeted therapy (Pluvicto). The treatment targets PSMA, a protein on prostate cancer cells, delivering radiation directly to those cells.
MSK also notes that the FDA approval expanded in 2025 to include more patients—specifically, people who had not yet received chemotherapy, increasing who may be eligible for this type of treatment.
Theranostics Beyond Prostate Cancer
Theranostics is also being developed for other cancers. MSK describes ongoing work to identify new targets, including efforts in neuroendocrine cancers and research into targets like DLL3. MSK researchers are also working toward theranostics applications in cancers such as breast cancer, brain tumors, melanoma, and pancreatic cancer.
What’s Next: A More Powerful Next Wave (Alpha Particles)
MSK highlights a “next wave” of theranostics using alpha-emitting radiopharmaceuticals—described as the most powerful form yet—and notes they opened a facility dedicated to producing these agents for clinical trials.
Questions to Ask Your Care Team
If you or a loved one is living with advanced cancer, you might consider asking:
- Do I have a target (biomarker) that could make me eligible for theranostics?
- Would a PET scan help identify targets or sites of disease more clearly?
- Are there clinical trials involving targeted radionuclide therapy that fit my diagnosis?
- What side effects are typical, and how might this compare to other options?
(This is informational only—your oncology team can help you understand what’s appropriate for your specific diagnosis.)
You’re Not Alone—Connect with the Stage 4 Hope Community
Whether you’re exploring treatment options, seeking emotional support, or trying to make sense of a new diagnosis, Stage 4 Hope is here for you. Join our community to access trusted resources, education, and encouragement from others who understand the stage 4 journey.
Reference:
https://www.mskcc.org/news/theranostics-powerful-diagnostic-tool-and-cancer-treatment-in-one
FIBER It Does a Body Good
Fiber and Cancer Prevention: Why It Matters
Should you be eating more fiber to help prevent cancer? And how much do you really need to reduce your risk?
It could be time for a fiber tune-up of your diet. Most American adults get only half the recommended daily dose, according to the Centers for Disease Control and Prevention (CDC).
Clinical dietitian-nutritionist Cara Anselmo, MS, RDN, is an expert in breast cancer nutrition and is a certified specialist in obesity and weight management.
“Eating more fiber is often overlooked as one of the healthiest things we can do for ourselves,” Anselmo says.
Fiber not only improves heart health, reduces diabetes risk, and aids in weight control, it may reduce the risk of several common cancers such as colorectal cancer.
How Does Fiber Reduce the Risk of Colorectal Cancer?
Dietary fiber has long been linked to a lower risk of certain types of cancer, particularly colorectal cancer. Colon cancer rates are increasing among young adults. Because less than 10% of adults are getting enough fiber, scientists think this trend may be connected.
One of the main ways that fiber helps to protect against colon cancer, according to Anselmo, is by fostering a healthy population of bacteria in the colon, known as the microbiome. Fiber remains in the colon after other components of the diet become absorbed by the body.
“When fiber is fermented by the bacteria in our colon,” Anselmo says, “it produces metabolites, which reduce inflammation and protect the colon cells from becoming cancerous. These metabolites can also activate our immune system and increase anti-cancer immunity.”
Fiber also has several other effects that improve our metabolic health, which indirectly lowers the risk of several cancers. For example, fiber can increase the speed at which food passes through the gut, which can lower absorption and exposure time to less healthy foods we may have consumed. Fiber can also lower cholesterol levels.
What Is a High-Fiber Diet?
A high-fiber diet means you eat foods that are rich in this type of carbohydrate, found mainly in plant foods such as fruits, vegetables, whole grains, beans, peas, and legumes. Consuming more than 25 to 30 grams of fiber per day is generally considered to be a high-fiber diet.
What Are the Kinds of Fiber?
There are two main types of dietary fiber — soluble and insoluble. Both types of fiber are healthy and can lower cancer risk.
Soluble fiber attracts water into the intestines and becomes a gel. It can help lower blood sugar and cholesterol levels. Foods higher in soluble fiber include:
• Oats
• Beans
• Citrus fruits
• Peas
Insoluble fiber doesn’t dissolve in water. It can help move food through your digestive system, absorb water to provide bulk, and may help prevent constipation. Foods higher in insoluble fiber include:
• Whole grains
• Some vegetables
• Nuts and seeds
How Much Fiber Do You Need?
The MSK registered dietitian-nutritionist team recommends that most people eat 25 grams of fiber per day. “Consume half of your fiber from whole foods like whole grains, vegetables, and beans,” Anselmo advises. “Fiber-supplemented products are not as effective as whole foods and may not have additional nutrients that help you reach your optimal health.”
Anselmo also stresses the importance of staying well hydrated when increasing dietary fiber in order to minimize potential symptoms such as bloating and abdominal discomfort as your gastrointestinal tract adapts to new changes. She reminds patients to always ask their cancer care team if they should follow any special diet before, during, or after treatment.
How Is MSK Researching the Role of Fiber and Cancer?
Studies are underway to help determine a person’s optimal dose of fiber to prevent cancer, based on their biology, genetics, and lifestyle.
MSK is also investigating which bacteria are involved in fermenting fiber into the metabolites that protect against various cancers, including breast, skin, prostate, colon, and rectal cancer. If scientists can identify a specific bacterial signature, other interventions such as bacterial transplants may work to reduce cancer risks.
Finally, there are ongoing studies testing whether fiber intake and certain probiotic compounds might enhance the effectiveness of chemotherapy and immunotherapy. (Source: Memorial Sloan Kettering News- 2025, Issue 1)
Resources for Living With Stage 4 Cancer
Learn more about topics like fiber and cancer prevention, the benefits of fasting, along with other important aspects of living with Stage 4 cancer. Become a member of our community to gain access to trusted resources, online support and education from Dr. Sharon May, Ph.D., LMFT, medical updates, and invitations to supportive virtual gatherings.
